Search

FDA Approves New Pancreatic Cancer Pill; Tyler Trial Shows Promising Results

The Food and Drug Administration Has Approved Daraxonrasib, a New Treatment for Metastatic Pancreatic Adenocarcinoma, as a Similar Drug in a Tyler Clinical Trial Yields Significant Progress for Patients.